{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:02:59Z","timestamp":1773770579004,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.schres.2013.07.039","type":"journal-article","created":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T18:55:12Z","timestamp":1376074512000},"page":"289-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: A randomized, double-blind, placebo-controlled study"],"prefix":"10.1016","volume":"150","author":[{"given":"James B.","family":"Lohr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lianqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Caligiuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor P.","family":"Kash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd A.","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jody DelaPena","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Ancoli-Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2013.07.039_bb0005","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0010","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00213-011-2513-z","article-title":"A placebo-controlled study of the modafinil added to risperidone in chronic schizophrenia","volume":"220","author":"Arbabi","year":"2012","journal-title":"Psychopharmacology (Berl)."},{"key":"10.1016\/j.schres.2013.07.039_bb0015","doi-asserted-by":"crossref","first-page":"554","DOI":"10.4088\/JCP.v67n0406","article-title":"A systematic review of modafinil: potential clinical uses and mechanisms of action","volume":"67","author":"Ballon","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0020","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.schres.2011.05.015","article-title":"The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia\/schizoaffective disorder: a randomized, double-blind, placebo-controlled trial","volume":"130","author":"Bobo","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2013.07.039_bb0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/13854049108403297","article-title":"The Hopkins Verbal Learning Test: development of a new memory test with six equivalent forms","volume":"5","author":"Brandt","year":"1991","journal-title":"Clin. Neuropsychol."},{"key":"10.1016\/j.schres.2013.07.039_bb0035","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1176\/jnp.9.4.562","article-title":"Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients","volume":"9","author":"Caligiuri","year":"1997","journal-title":"J. Neuropsychiatry. Clin. Neurosci."},{"key":"10.1016\/j.schres.2013.07.039_bb0040","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1176\/ajp.150.9.1343","article-title":"Parkinsonism in neuroleptic-naive schizophrenic patients","volume":"150","author":"Caligiuri","year":"1993","journal-title":"Am. J. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2013.07.039_bb0045","first-page":"9","article-title":"What are we looking for in new antipsychotics?","volume":"72","author":"Correll","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00003088-200847010-00006","article-title":"Interaction profile of armodafinil with medications metabolized by cytochrome P450 enzymes 1A2, 3A4 and 2C19 in healthy subjects","volume":"47","author":"Darwish","year":"2008","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.schres.2013.07.039_bb0055","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1177\/0269881112447988","article-title":"Anticholinergics in the era of atypical antipsychotics: short-term or long-term treatment?","volume":"26","author":"Desmarais","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.schres.2013.07.039_bb0060","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/jnr.10196","article-title":"Differential enhancement of dialysate serotonin levels in distinct brain regions of the awake rat by modafinil: possible relevance for wakefulness and depression","volume":"68","author":"Ferraro","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.schres.2013.07.039_bb0065","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2013.07.039_bb0070","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.4088\/JCP.08m04683","article-title":"Modafinil for clozapine-treated schizophrenia patients: a double-blind, placebo-controlled pilot trial","volume":"70","author":"Freudenreich","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0075","first-page":"349","article-title":"Mechanisms of modafinil: a review of current research","volume":"3","author":"Gerrard","year":"2007","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2013.07.039_bb0080","series-title":"Stroop Color and Word Test: A Manual For Clinical and Experimental Uses Stoelting Co","author":"Golden","year":"1978"},{"key":"10.1016\/j.schres.2013.07.039_bb0085","first-page":"RA177","article-title":"Modafinil for narcolepsy: systematic review and meta-analysis","volume":"16","author":"Golicki","year":"2010","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.schres.2013.07.039_bb0090","series-title":"ECDEU Assessment Manual for Psychopharmacology, revised","first-page":"534","article-title":"Abnormal Involuntary Movement Scale (AIMS)","author":"Guy","year":"1976"},{"key":"10.1016\/j.schres.2013.07.039_bb0095","series-title":"ECDEU Assessment Manual for Psychopharmacology - Revised (DHEW Publ No ADM 76\u2013338)","first-page":"218","author":"Guy","year":"1976"},{"key":"10.1016\/j.schres.2013.07.039_bb0100","series-title":"The Wisconsin Card Sorting Test: 64 card research edition Psychological Assessment Resources, Inc.","author":"Heaton","year":"1998"},{"key":"10.1016\/j.schres.2013.07.039_bb0105","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1176\/ajp.2006.163.12.2184","article-title":"Impact of modafinil on prefrontal executive function in schizophrenia","volume":"163","author":"Hunter","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0110","first-page":"62","article-title":"Sleep-disordered breathing: in depression and schizophrenia","volume":"3","author":"Jaffe","year":"2006","journal-title":"Psychiatry (Edgmont)"},{"key":"10.1016\/j.schres.2013.07.039_bb0115","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/j.schres.2013.07.039_bb0120","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.4088\/JCP.09m05950gry","article-title":"Armodafinil as adjunctive therapy in adults with cognitive deficits associated with schizophrenia: a 4-week, double-blind, placebo-controlled study","volume":"71","author":"Kane","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0125","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.schres.2011.11.006","article-title":"Adjunctive armodafinil for negative symptoms in adults with schizophrenia: a double-blind, placebo-controlled study","volume":"135","author":"Kane","year":"2012","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2013.07.039_bb0130","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2013.07.039_bb0135","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2165\/00023210-200519090-00005","article-title":"Modafinil: a review of its use in excessive sleepiness associated with obstructive sleep apnoea\/hypopnoea syndrome and shift work sleep disorder","volume":"19","author":"Keating","year":"2005","journal-title":"Cns Drugs"},{"key":"10.1016\/j.schres.2013.07.039_bb0140","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev-med-050911-161504","article-title":"Update on typical and atypical antipsychotic drugs","volume":"64","author":"Meltzer","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.schres.2013.07.039_bb0145","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/sj.npp.1301534","article-title":"Modafinil: a review of neurochemical actions and effects on cognition","volume":"33","author":"Minzenberg","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2013.07.039_bb0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.pbb.2008.07.014","article-title":"Behavioral responses of dopamine beta-hydroxylase knockout mice to modafinil suggest a dual noradrenergic-dopaminergic mechanism of action","volume":"91","author":"Mitchell","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.schres.2013.07.039_bb0155","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/schbul\/sbl051","article-title":"Psychomotor slowing in schizophrenia","volume":"33","author":"Morrens","year":"2007","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2013.07.039_bb0160","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/archpsyc.59.3.292","article-title":"Is psychosis exacerbated by modafinil?","volume":"59","author":"Narendran","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0165","doi-asserted-by":"crossref","first-page":"705","DOI":"10.4088\/JCP.v68n0507","article-title":"A randomized, double-blind, placebo-controlled trial of modafinil for negative symptoms in schizophrenia","volume":"68","author":"Pierre","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0170","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1176\/appi.ajp.2007.07081279","article-title":"Treatment-emergent hypomania or mania with modafinil","volume":"165","author":"Plante","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0175","series-title":"The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation","author":"Reitan","year":"1998"},{"key":"10.1016\/j.schres.2013.07.039_bb0185","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00002826-200401000-00011","article-title":"Benefits of adjunct modafinil in an open-label, pilot study in patients with schizophrenia","volume":"27","author":"Rosenthal","year":"2004","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.schres.2013.07.039_bb0180","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/NMD.0b013e31816ff3bf","article-title":"The Epworth sleepiness scale in the identification of obstructive sleep apnea","volume":"196","author":"Rosenthal","year":"2008","journal-title":"J. Nerv. Ment. Dis."},{"key":"10.1016\/j.schres.2013.07.039_bb0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/schbul\/sbq042","article-title":"Second-generation antipsychotic drugs and extrapyramidal side effects: a systematic review and meta-analysis of head-to-head comparisons","volume":"38","author":"Rummel-Kluge","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2013.07.039_bb0195","doi-asserted-by":"crossref","first-page":"104","DOI":"10.4088\/JCP.07r03982","article-title":"Modafinil as an adjunctive treatment of sedation, negative symptoms, and cognition in schizophrenia: a critical review","volume":"70","author":"Saavedra-Velez","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00213-011-2472-4","article-title":"Effects of modafinil on cognitive functions in first episode psychosis","volume":"220","author":"Scoriels","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.schres.2013.07.039_bb0205","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neuropharm.2012.07.011","article-title":"Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain","volume":"64","author":"Scoriels","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.schres.2013.07.039_bb0210","doi-asserted-by":"crossref","first-page":"839","DOI":"10.4088\/JCP.v66n0705","article-title":"Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications","volume":"66","author":"Sevy","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0215","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.schres.2013.07.039_bb0220","series-title":"A Compendium of Neuropsychological Tests: Administration, Norms and Commentary","author":"Spreen","year":"1998"},{"key":"10.1016\/j.schres.2013.07.039_bb0225","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11940-009-0019-3","article-title":"Drug-induced parkinsonism","volume":"11","author":"Susatia","year":"2009","journal-title":"Curr. Treat Options Neurol."},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2013.07.039_bb0230","first-page":"4","article-title":"Antipsychotics in the treatment of schizophrenia: an overview","volume":"72","author":"Tandon","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0235","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2174\/138920008784746373","article-title":"Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions","volume":"9","author":"Urichuk","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.schres.2013.07.039_bb0240","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jama.2009.351","article-title":"Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications","volume":"301","author":"Volkow","year":"2009","journal-title":"JAMA."},{"key":"10.1016\/j.schres.2013.07.039_bb0245","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000339456","article-title":"Motor symptoms and schizophrenia","volume":"66","author":"Walther","year":"2012","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.schres.2013.07.039_bb0250","series-title":"Wechsler Adult Intelligence Scale","author":"Wechsler","year":"1997"},{"key":"10.1016\/j.schres.2013.07.039_bb0255","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.4088\/JCP.v67n1122a","article-title":"Manic switch in a patient with treatment-resistant bipolar depression treated with modafinil","volume":"67","author":"Wolf","year":"2006","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2013.07.039_bb0260","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1445-5994.2008.01710.x","article-title":"Modafinil-induced psychosis","volume":"38","author":"Wu","year":"2008","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.schres.2013.07.039_bb0265","first-page":"301","article-title":"Neuroprotective mechanism of modafinil on Parkinson disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"25","author":"Xiao","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.schres.2013.07.039_bb0270","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/npp.2011.23","article-title":"Dopamine receptor mediation of the exploratory\/hyperactivity effects of modafinil","volume":"36","author":"Young","year":"2011","journal-title":"Neuropsychopharmacol."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996413004003?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996413004003?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T15:25:52Z","timestamp":1563636352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996413004003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0920996413004003"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2013.07.039","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: A randomized, double-blind, placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2013.07.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}